Measles immunization — all countries

Measles immunization — Northern Europe

Measles immunization in Northern Europe in 2024 — 90.4%. Since 1992, the indicator has fallen by 1.6 pp.

2024 90.4% −0.7 pp vs 2023
World rank
Period maximum 93.7%2015
Period minimum 85.8%2004

Trend over time

1992–2024 · % of children aged 12–23 months

Measles immunization — Northern Europe, 1992–20248486889092941992199620002004200820122016202020241992: 92%1993: 90.5%1994: 91.1%1995: 91.6%1996: 91.9%1997: 91.2%1998: 88.9%1999: 89.1%2000: 89.6%2001: 87.6%2002: 87.7%2003: 86%2004: 85.8%2005: 86.5%2006: 88.3%2007: 88.8%2008: 88.8%2009: 88.7%2010: 90.7%2011: 91.3%2012: 92.7%2013: 93.4%2014: 93.5%2015: 93.7%2016: 93%2017: 93.2%2018: 93.1%2019: 92.6%2020: 92.4%2021: 92.2%2022: 91.1%2023: 91%2024: 90.4%
Change over the period: −1.6 pp Annual average: -0.05 pp

Comparison, 2024

How the value compares with the world and the groups this territory belongs to: Northern Europe

Northern Europe 90.4%
World 84.3%
Measles immunization — Northern Europe, by year Northern Europe All countries CSV XLSX
Year % Change, pp
2024 90.4 −0.7 pp
2023 91 −0.1 pp
2022 91.1 −1.1 pp
2021 92.2 −0.3 pp
2020 92.4 −0.2 pp
2019 92.6 −0.5 pp
2018 93.1 −0.1 pp
2017 93.2 +0.2 pp
2016 93 −0.6 pp
2015 93.7 +0.2 pp
2014 93.5 +0 pp
2013 93.4 +0.7 pp
2012 92.7 +1.4 pp
2011 91.3 +0.6 pp
2010 90.7 +2 pp
2009 88.7 −0.1 pp
2008 88.8 −0 pp
2007 88.8 +0.5 pp
2006 88.3 +1.9 pp
2005 86.5 +0.7 pp
2004 85.8 −0.3 pp
2003 86 −1.6 pp
2002 87.7 +0 pp
2001 87.6 −2 pp
2000 89.6 +0.6 pp
1999 89.1 +0.2 pp
1998 88.9 −2.4 pp
1997 91.2 −0.7 pp
1996 91.9 +0.3 pp
1995 91.6 +0.6 pp
1994 91.1 +0.5 pp
1993 90.5 −1.5 pp
1992 92

About the indicator

The share of children aged 12–23 months who have been vaccinated against measles. Measles is more contagious than almost any other infection, and its threshold of herd immunity is higher than the rest — about 95% — so a fall in coverage by a few points brings outbreaks back to countries where the disease was considered beaten. This series shows how coverage sagged in 2020–2021 and where it has not recovered since.

Important: The first dose. Reliable protection requires two, and coverage of the second dose is lower; the World Bank has no separate series for it.

Source: Global Health Observatory (WHO), license CC BY-NC-SA 3.0 IGO.